Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Inks Deal with iPS Academia Japan

NEW YORK (GenomeWeb News) – Life Technologies today announced a worldwide, non-exclusive deal with iPS Academia Japan for its induced pluripotent stem cell patent portfolio.

The agreement grants Life Tech the rights to commercialize a range of products and services designed to create iPS cells and differentiate them into any cell type for drug discovery and pre-clinical research. Life Tech will also be able to provide iPS cell creation, differentiation, and screening services to the scientific community.

"Because iPS cells are gaining greater attention for uses in drug discovery and disease research as well as other areas of biotechnology, distribution of iPS cell products or provision of services is important for gaining momentum in iPS cell research," Shosaku Murayama, president and CEO of iPS Academia Japan, said in a statement. "We believe that Life Technologies' business will contribute to boost research and development for practical application of iPS cell technology."

Life Tech President and COO Mark Stevenson added, "With this license now in place, we are furthering our commitment to the stem cell field and to developing a full breadth of products and services for our customers whether they are in basic research, drug discovery and development, or moving toward clinical applications."

Financial and other terms were not disclosed.

The deal is the second announced by Life Tech this week in the area of stem cells. Earlier it said it had reached a product commercialization agreement with Cellular Dynamics International.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.